Erbez Georgia — SEC Form 4 filings
SEC reporting owner CIK 1557930. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-25.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-22 to 2026-02-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 10,065 shares, $20,630 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 6,239 shares @ $2.50 ($15,629) in CODEXIS, INC., filed 2025-10-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CODEXIS, INC. (CDXS) | See Remarks | 5 | — | 2 legs · 10,065 sh · $20,630 | 5 |
| Coherus Oncology, Inc. (CHRS) | Director | 3 | — | — | 3 |
Form 4 filings — Erbez Georgia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-25 | 4 | CODEXIS, INC. (CDXS) | Grant/award (A): 316,100 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | CODEXIS, INC. (CDXS) | Sale (S): 3,826 @ $1.31 | EDGAR |
| 2025-10-15 | 4 | CODEXIS, INC. (CDXS) | Sale (S): 6,239 @ $2.50 | EDGAR |
| 2025-06-13 | 4 | Coherus Oncology, Inc. (CHRS) | Grant/award (A): 112,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | CODEXIS, INC. (CDXS) | Grant/award (A): 26,875 @ $0 · Grant/award (A): 161,250 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | CODEXIS, INC. (CDXS) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Coherus BioSciences, Inc. (CHRS) | Grant/award (A): 114,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Coherus BioSciences, Inc. (CHRS) | Grant/award (A): 54,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557930 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →